Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia

NCT06183307 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Dyslipidemias
Inflammation

Interventions

DIETARY_SUPPLEMENT: Nattokinase
DIETARY_SUPPLEMENT: Placebo

Sponsor

Universidade Federal Fluminense

Collaborators

[object Object]
[object Object]
[object Object]